Global Partnerships
At Solis Pharmaceuticals, we are committed to expanding patient access to high-quality medicines through strategic global collaborations. Our partnership model is designed to build long-term relationships with pharmaceutical companies, distributors, and innovators worldwide.
We follow a dual growth strategy
- Out-Licensing of Our Portfolio (Ex-United States)
- Strategic In-Licensing & Co-Development Partnerships
Out-Licensing Opportunities
(Ex-United States)
Solis Pharmaceuticals directly commercializes its product portfolio within the United States. For markets outside the U.S., we are actively seeking experienced pharmaceutical partners for licensing, distribution, and commercialization.
We welcome collaboration with partners who have strong regulatory expertise, market presence, and commercialization capabilities in their respective territories.
Available Portfolio for Licensing
9 Products
| Sr. No. | Product Name |
|---|---|
| 1 | Cilostazol Tablet 50mg & 100mg |
| 2 | Dapsone Tablet 25mg & 100mg |
| 3 | Piroxicam Capsule 10mg & 20mg |
| 4 | Fluoxetine HCL Oral Solution 20mg/5mL |
| 5 | Homatropine & Hydrocodone Oral Syrup 1.5mg; 5mg/5mL |
| 6 | Morphine sulphate Oral Solution 10mg/5mL, 20mg/5mL & 100mg/5mL |
| 7 | Oxycodone and Acetaminophen Oral Solution 5mg; 325mg/5mL |
| 8 | Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride powder for solution 420gm; 1.48gm; 5.72gm; 11.2gm/bottle |
| 9 | Theophylline Oral Solution (Elixir) 80mg/15mL |
Products of Interest –
Strategic Collaboration
Solis is actively seeking innovative, specialty, and high-value pharmaceutical products to expand our Global portfolio.
We are open to multiple partnership structures like In-Licensing (Exclusive / Semi-Exclusive), Co-Development, Joint Ventures, Distribution Agreements, and Asset Acquisition for the following products
Product List
16 Products
| Sr. No. | Product Name |
|---|---|
| 1 | Brimonidine Tartrate Solution/Drops 0.025% |
| 2 | Bromfenac Sodium Solution/Drops Eq 0.075% Acid |
| 3 | Cefixime For Suspension 500mg/5mL |
| 4 | Clozapine Suspension 50mg/mL |
| 5 | Dexamethasone; Tobramycin Suspension/Drops 0.05%;0.3% |
| 6 | Ketorolac Tromethamine Solution/Drops 0.45% |
| 7 | Latanoprost Emulsion 0.005% |
| 8 | Latanoprostene Bunod Solution/Drops 0.024% |
| 9 | Omaveloxolone Capsule 50mg |
| 10 | Prednisolone Acetate Suspension Eq 15mg Base/5mL |
| 11 | Prednisolone Acetate Suspension Eq 5mg Base/5mL |
| 12 | Riluzole Suspension 50mg/10mL |
| 13 | Risedronate Sodium Tablet, Delayed Release 35mg |
| 14 | Risperidone For Suspension, Extended Release 90mg |
| 15 | Selumetinib Sulfate Capsule Eq 10mg Base |
| 16 | Triamcinolone Acetonide Injectable 40mg/mL |
Let’s Connect
Whether you are looking to expand your product globally or seeking a strong U.S. partner for commercialization, Solis welcomes confidential partnership discussions.
Together, we can bring high-quality therapies to patients worldwide.
